My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 218

    1.

    Use of levosimendan for cardiogenic shock in a patient with the apical ballooning syndrome.

    De Santis V, Vitale D, Tritapepe L, Greco C, Pietropaoli P.

    Ann Intern Med. 2008 Sep 2;149(5):365-7. No abstract available. PMID: 18765717 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Levosimendan: the inotrope of choice in cardiogenic shock secondary to takotsubo cardiomyopathy?

    Padayachee L.

    Heart Lung Circ. 2007;16 Suppl 3:S65-70. Epub 2007 Jul 5.PMID: 17616435 [PubMed - indexed for MEDLINE]Related articles

    3.

    Use of levosimendan for treatment of cardiogenic shock associated with electrical storm.

    Grazi M, Lauri G, Carbucicchio C, Marenzi G.

    Ann Intern Med. 2009 May 19;150(10):738-40. No abstract available. PMID: 19451590 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Levosimendan is superior to enoximone in refractory cardiogenic shock complicating acute myocardial infarction.

    Beute J.

    Crit Care Med. 2009 Sep;37(9):2678; author reply 2678-9. No abstract available. PMID: 19687655 [PubMed - indexed for MEDLINE]Related articles

    5.

    Levosimendan in cardiogenic shock: the magic drug for every patient?

    Smetana P, Geppert A.

    Crit Care Med. 2007 Dec;35(12):2862-4. No abstract available. PMID: 18043208 [PubMed - indexed for MEDLINE]Related articles

    6.

    [Successful use of levosimendan in a patient with cardiogenic shock complicating acute myocardial infarction]

    Mustapha F, Moufida H, Nedia B, Anis L, Iheb L, Habib H.

    Tunis Med. 2005 Oct;83(10):635-7. French. PMID: 16370217 [PubMed - indexed for MEDLINE]Related articles

    7.

    Levosimendan in cardiogenic shock: better than enoximone!

    Buerke M, Prondzinsky R.

    Crit Care Med. 2008 Aug;36(8):2450-1. No abstract available. PMID: 18664796 [PubMed - indexed for MEDLINE]Related articles

    8.

    Levosimendan or enoximone in refractory cardiogenic shock?

    Berthelsen PG.

    Crit Care Med. 2009 Mar;37(3):1182. No abstract available. PMID: 19237971 [PubMed - indexed for MEDLINE]Related articles

    9.

    Levosimendan: right for the right ventricle?

    Lambermont B, Ghuysen A, Harstein G, D'Orio V.

    Crit Care Med. 2007 Aug;35(8):1995-6. No abstract available. PMID: 17667254 [PubMed - indexed for MEDLINE]Related articles

    10.

    Evaluation of 30-day mortality of levosimendan versus enoximone.

    Rijnders BJ.

    Crit Care Med. 2009 Mar;37(3):1181-2. No abstract available. PMID: 19237968 [PubMed - indexed for MEDLINE]Related articles

    11.

    Levosimendan reversing low output syndrome after heart transplantation.

    Petäjä LM, Sipponen JT, Hämmäinen PJ, Eriksson HI, Salmenperä MT, Suojaranta-Ylinen RT.

    Ann Thorac Surg. 2006 Oct;82(4):1529-31.PMID: 16996977 [PubMed - indexed for MEDLINE]Related articles

    12.

    Utility of levosimendan, a new calcium sensitizing agent, in the treatment of cardiogenic shock due to myocardial stunning in patients with ST-elevation myocardial infarction: a series of cases.

    García-González MJ, Domínguez-Rodríguez A, Ferrer-Hita JJ.

    J Clin Pharmacol. 2005 Jun;45(6):704-8. No abstract available. PMID: 15901754 [PubMed - indexed for MEDLINE]Related articles

    13.

    Levosimendan as rescue therapy in severe cardiogenic shock after ST-elevation myocardial infarction.

    Greif M, Zwermann L, Reithmann C, Weis M.

    Acute Card Care. 2008;10(3):185-90.PMID: 18972629 [PubMed - indexed for MEDLINE]Related articles

    14.

    [Levosimendan for treatment of heart failure]

    Yasumura Y.

    Nippon Rinsho. 2007 May 28;65 Suppl 5:169-72. Review. Japanese. No abstract available. PMID: 17571380 [PubMed - indexed for MEDLINE]Related articles

    15.

    Treatment of cardiogenic shock with levosimendan in combination with beta-adrenergic antagonists.

    Alhashemi JA.

    Br J Anaesth. 2005 Nov;95(5):648-50. Epub 2005 Sep 2.PMID: 16143579 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Hemodynamic improvement following levosimendan treatment in patients with acute myocardial infarction and cardiogenic shock.

    Russ MA, Prondzinsky R, Christoph A, Schlitt A, Buerke U, Söffker G, Lemm H, Swyter M, Wegener N, Winkler M, Carter JM, Reith S, Werdan K, Buerke M.

    Crit Care Med. 2007 Dec;35(12):2732-9.PMID: 17893627 [PubMed - indexed for MEDLINE]Related articles

    17.

    Effects of levosimendan versus dobutamine on long-term survival of patients with cardiogenic shock after primary coronary angioplasty.

    Samimi-Fard S, García-González MJ, Domínguez-Rodríguez A, Abreu-González P.

    Int J Cardiol. 2008 Jul 4;127(2):284-7. Epub 2007 Jul 23.PMID: 17643519 [PubMed - indexed for MEDLINE]Related articles

    18.

    Cardiogenic shock after primary percutaneous coronary intervention: Effects of levosimendan compared with dobutamine on haemodynamics.

    García-González MJ, Domínguez-Rodríguez A, Ferrer-Hita JJ, Abreu-González P, Muñoz MB.

    Eur J Heart Fail. 2006 Nov;8(7):723-8. Epub 2006 Feb 21.PMID: 16492404 [PubMed - indexed for MEDLINE]Related articles

    19.

    [Treatment of cardiogenic shock with the Ca2+ sensitizer levosimendan]

    Zobel C, Reuter H, Schwinger RH.

    Med Klin (Munich). 2004 Dec 15;99(12):742-6. German. PMID: 15599685 [PubMed - indexed for MEDLINE]Related articles

    20.

    Evidence-based use of levosimendan in different clinical settings.

    De Luca L, Colucci WS, Nieminen MS, Massie BM, Gheorghiade M.

    Eur Heart J. 2006 Aug;27(16):1908-20. Epub 2006 Apr 27. Review.PMID: 16682381 [PubMed - indexed for MEDLINE]Related articlesFree article

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity